IP Library Granted Patent US 7,635,759
Granted Patent B2
US 7,635,759 · App. 12/029,113 · Granted Dec 22, 2009

Gene encoding labyrinthin, a marker for cancer

Assignee: Immvarx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,635,759
App. No.
12/029,113
Granted
Dec 22, 2009
Kind
B2
Abstract

A cDNA molecule that encodes a protein designated Labyrinthin (Lab) is isolated and its nucleotide sequence is determined. The protein, or peptides derived from the protein, are markers useful to define novel classes of cancers. Diagnostic assays for these cancers use antibodies to Lab or nucleotide probes that hybridize with the lab gene or a fragment therefrom. Vaccines useful either to prevent recurrence of cancers in subjects who test positive for Lab (or lab) or to prevent initial occurrence of cancer, use proteins or peptides derived from Lab. Expression of Lab via immunogenic assays is used to monitor effects of cancer treatments. Antisense molecules against lab are used in treatments. Sense molecules of lab are used to restore lost lab function in diseased normal cells, for example, gland cells.

Claims (3)

1. An isolated antibody that is directed specifically to a peptide consisting of an amino acid sequence selected from the group consisting of APPEDNPVED (SEQ ID NO: 6), EEQQEVPPDT (SEQ ID NO: 7), DGPTGEPQQE (SEQ ID NO: 8), EQENPDSSEPV (SEQ ID NO: 9) and PTGEPQ (SEQ ID NO: 10).

2. The antibody of claim 1 is a humanized antibody.

3. The antibody of claim 1 is a monoclonal antibody.

Assignments (3)
MERGER Recorded Jan 16, 2018
From: IMMVARX, INC.
To: MISSION THERAPEUTICS, INC.
Reel/Frame 044632/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: MISSION THERAPEUTICS, INC.
To: OPUS CRYSTAL HOLDINGS LIMITED
Reel/Frame 044632/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2008
From: RADOSEVICH, JAMES A.
To: IMMVARX, INC.
Reel/Frame 021074/0628 →
Continuity (5)
Continuation 1083070200 · Apr 23, 2004
Division 0965952100 · Sep 12, 2000
Continuation PCTUS990536500 · Mar 11, 1999
Continuation In Part 0904048500 · Mar 17, 1998
Related Publication 20080249284A1 · Oct 9, 2008